SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacyclics (PCYC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (422)3/28/1999 1:30:00 PM
From: Biomaven  Read Replies (1) of 717
 
Thanks, John - I hadn't seen the Wired article yet. I've dubbed this PCYC's "roto-rooter" application, and it certainly could be a blockbuster if it pans out. Still very early days though. QLTIF's photofrin wouldn't work in this application because it uses a different wavelength that doesn't penetrate blood.

I've been buying PCYC on the dips. I might well be too early, as the Gd-Tex Phase III trials which should be the primary driver of the stock are just beginning. However, success in either Gd-Tex or the roto-rooter would make this stock a 10-bagger, so I'm prepared to wait.

The stock is still suffering some as analysts pull back from their earlier ridiculously optimistic near-term earnings projections. At some point of course the stock will be driven by its trial results, not by the analyst projections.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News